CW

Charles Walker

Mr Walker has experience across the biotechnology and life sciences industry. His experience includes operational and leadership positions in biotechnology firms, a capital markets track record from executing nearly 60 international and domestic corporate transactions, both as principal and advisor, and a detailed scientific understanding gained from a technical background in pharmacology. He is also chair of Risk Committee.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
30/06/232,295,81720,275,210606,669N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
15/12/22
Issued
600,000$0.175$105,000Issue of options
04/11/22
Exercise
25,000,000$0.043$1,070,000Exercise of options
04/11/22
Sell
8,250,000$0.195$1,610,400On-market trade
04/11/22
Buy
25,000,000$0.043$1,070,000Exercise of options
09/06/22
Buy
128,000$0.155$19,840On-market trade